PRFX - PainReform regains compliance with Nasdaq's minimum bid price rule
2023-07-19 09:19:52 ET
- PainReform ( NASDAQ: PRFX ) said on Wednesday that the specialty pharmaceutical company has regained compliance with Nasdaq's minimum bid price requirement.
- PRFX shares were trading +0.52% pre-market.
- Source: Press Release
For further details see:
PainReform regains compliance with Nasdaq's minimum bid price rule